Health-related quality-of-life in patients with newly diagnosed multiple myeloma in the FIRST trial: lenalidomide plus low-dose dexamethasone versus melphalan, prednisone, thalidomide.
Haematologica
; 100(6): 826-33, 2015 Jun.
Article
in En
| MEDLINE
| ID: mdl-25769541
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Quality of Life
/
Antineoplastic Combined Chemotherapy Protocols
/
Health Status
/
Multiple Myeloma
Type of study:
Clinical_trials
/
Diagnostic_studies
/
Observational_studies
/
Prevalence_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Aged
/
Aged80
/
Female
/
Humans
/
Male
Language:
En
Journal:
Haematologica
Year:
2015
Type:
Article
Affiliation country:
Belgium